Cetera Investment Advisers
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1666741
SCHAUMBURG, IL
Position in TEVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,626,945
+$741,019 QoQ
Shares Held
87,216
+44.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in TEVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,626,945 | 87,216 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,885,926 | 60,427 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $953,743 | 47,215 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $659,925 | 39,375 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $836,589 | 54,430 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,170,434 | 53,105 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $973,152 | 54,004 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $989,105 | 60,868 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $467,083 | 33,103 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $255,508 | 24,474 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $287,487 | 28,185 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $247,187 | 32,827 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $287,704 | 32,509 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $308,593 | 33,837 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $157,615 | 19,531 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $280,653 | 37,321 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $353,965 | 37,696 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $301,872 | 37,687 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $360,642 | 37,027 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $373,477 | 37,725 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $419,328 | 36,337 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $386,173 | 40,018 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||